Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RUCONEST
- Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
- Prevention of Acute Kidney Injury in Patients With NSTEMI
- Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection
- Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
- RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
- Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
- A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration
- Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
- Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Clinical trials list
click for details